Clinical Trial Update: A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the Retina [Phase 3]

View source ↗

Summary

Phase 3 study evaluating an updated dexamethasone intravitreal applicator for macular edema due to retinal diseases; study completed with results posted in 2023…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema

Drugs mentioned

• Dexamethasone intravitreal implant/applicator (updated) (dexamethasone intravitreal)

Snippet

Sponsor: AbbVie | Conditions: Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2023-02-28